{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:41:50Z","timestamp":1783399310029,"version":"3.54.6"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2022010"],"award-info":[{"award-number":["2022010"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["272681"],"award-info":[{"award-number":["272681"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010745","name":"Norske Legeforening","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010745","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019647","name":"Kavlifondet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U01 AI090905"],"award-info":[{"award-number":["U01 AI090905"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbi.2025.106098","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T14:13:41Z","timestamp":1756649621000},"page":"106098","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)"],"prefix":"10.1016","volume":"130","author":[{"given":"Donia Jamal","family":"Ramadan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine M.","family":"Kichula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Porfilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asgeir","family":"Lande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Fluge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Mella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin Bolle","family":"Strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola Didrik","family":"Saugstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedicte A.","family":"Lie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marte K.","family":"Viken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bbi.2025.106098_b0005","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bjd.14081","article-title":"Inhibitory KIR3DL1 alleles are associated with psoriasis","volume":"174","author":"Ahn","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbi.2025.106098_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.674778","article-title":"High-resolution characterization of KIR genes in a large North American Cohort reveals novel details of structural and sequence diversity","volume":"12","author":"Amorim","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2025.106098_b0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.immuni.2006.06.013","article-title":"Human NK cell education by inhibitory receptors for MHC class I","volume":"25","author":"Anfossi","year":"2006","journal-title":"Immunity."},{"key":"10.1016\/j.bbi.2025.106098_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1386607","article-title":"Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: the biology of a neglected disease","volume":"15","author":"Arron","year":"2024","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.bbi.2025.106098_b0025","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","article-title":"NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs","volume":"121","author":"B\u00e9ziat","year":"2013","journal-title":"Blood."},{"issue":"4","key":"10.1016\/j.bbi.2025.106098_b0030","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.4049\/jimmunol.1002653","article-title":"Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis","volume":"186","author":"Bowness","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2025.106098_b0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13317-013-0051-x","article-title":"Natural killer cells in patients with severe chronic fatigue syndrome","volume":"4","author":"Brenu","year":"2013","journal-title":"Autoimmun. Highlights."},{"issue":"1","key":"10.1016\/j.bbi.2025.106098_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-8-1","article-title":"Immune and hemorheological changes in Chronic Fatigue Syndrome","volume":"8","author":"Brenu","year":"2010","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.bbi.2025.106098_b0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/intimm\/dxt068","article-title":"Role of adaptive and innate immune cells in chronic fatigue syndrome\/myalgic encephalomyelitis","volume":"26","author":"Brenu","year":"2014","journal-title":"Int. Immunol."},{"issue":"3","key":"10.1016\/j.bbi.2025.106098_b0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/039463200902200320","article-title":"Molecular Study of Receptor for Advanced Glycation Endproduct Gene Promoter and Identification of Specific HLA Haplotypes Possibly Involved in Chronic Fatigue Syndrome","volume":"22","author":"Carlo-Stella","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2025.106098_b0055","first-page":"7","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols","volume":"11","author":"Carruthers","year":"2003","journal-title":"JCFS."},{"issue":"11","key":"10.1016\/j.bbi.2025.106098_b0060","first-page":"3586","article-title":"Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin\u2010like receptor KIR3DL2 in spondylarthritis","volume":"52","author":"Chan","year":"2005","journal-title":"A&R."},{"key":"10.1016\/j.bbi.2025.106098_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.667336","article-title":"Next-generation sequencing identifies extended HLA class I and II haplotypes associated with early-onset and late-onset myasthenia gravis in Italian, Norwegian, and Swedish populations","volume":"12","author":"Creary","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2025.106098_b0070","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3844\/ajbbsp.2010.120.135","article-title":"The development of a revised Canadian myalgic encephalomyelitis-chronic fatigue syndrome case definition","volume":"6","author":"De Meirleir","year":"2010","journal-title":"Am. J. Biochem. Biotechnol."},{"key":"10.1016\/j.bbi.2025.106098_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1467304","article-title":"Entry into the lytic cycle exposes EBV-infected cells to NK cell killing via upregulation of the MICB ligand for NKG2D and activation of the CD56bright and NKG2A+ KIR+ CD56dim subsets","volume":"15","author":"Desimio","year":"2024","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2025.106098_b0080","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gepi.10252","article-title":"Pedigree disequilibrium tests for multilocus haplotypes","volume":"25","author":"Dudbridge","year":"2003","journal-title":"Genet. Epidemiol: The Official Publication of the International Genetic Epidemiology Society."},{"issue":"3","key":"10.1016\/j.bbi.2025.106098_b0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1755-0998.2010.02847.x","article-title":"Arlequin suite ver 3.5: a new series of programs to perform population genetics analyses under Linux and Windows","volume":"10","author":"Excoffier","year":"2010","journal-title":"Mol. Ecol. Resour."},{"issue":"5","key":"10.1016\/j.bbi.2025.106098_b0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010817","article-title":"Biomarkers in Chronic Fatigue Syndrome: Evaluation of Natural Killer Cell Function and Dipeptidyl Peptidase IV\/CD26","volume":"5","author":"Fletcher","year":"2010","journal-title":"PLoS ONE."},{"issue":"5","key":"10.1016\/j.bbi.2025.106098_b0095","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.4049\/jimmunol.166.5.2992","article-title":"Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism","volume":"166","author":"Gardiner","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2025.106098_b0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbi.2021.08.219","article-title":"Fine mapping of the major histocompatibility complex (MHC) in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) suggests involvement of both HLA class I and class II loci","volume":"98","author":"Hajdarevic","year":"2021","journal-title":"Brain. Behav. Immun."},{"issue":"8","key":"10.1016\/j.bbi.2025.106098_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011523","article-title":"The viral origin of myalgic encephalomyelitis\/chronic fatigue syndrome","volume":"19","author":"Hanson","year":"2023","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.bbi.2025.106098_b0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12865-015-0101-4","article-title":"Characterisation of cell functions and receptors in Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis (CFS\/ME)","volume":"16","author":"Hardcastle","year":"2015","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bbi.2025.106098_b0115","doi-asserted-by":"crossref","unstructured":"Huth T, Brenu E, Staines D, Marshall-Gradisnik S. Killer cell immunoglobulin-like receptor genotype and haplotype investigation of natural killer cells from an Australian population of chronic fatigue syndrome\/myalgic Encephalomyelitis patients. Gene. Regul. Syst. Bio. 2016;10:GRSB. S39861.","DOI":"10.4137\/GRSB.S39861"},{"key":"10.1016\/j.bbi.2025.106098_b0120","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2018.00330","article-title":"The development of the DePaul Symptom Questionnaire: Original, expanded, brief, and pediatric versions","volume":"6","author":"Jason","year":"2018","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.bbi.2025.106098_b0125","doi-asserted-by":"crossref","DOI":"10.1128\/jcm.28.6.1403-1410.1990","article-title":"Immunologic abnormalities in chronic fatigue syndrome","volume":"28","author":"Klimas","year":"1990","journal-title":"J. Clin. Microbiol."},{"issue":"1","key":"10.1016\/j.bbi.2025.106098_b0130","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1038\/s41598-020-62157-x","article-title":"Human leukocyte antigen alleles associated with myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"10","author":"Lande","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbi.2025.106098_b0135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12967-020-02269-0","article-title":"Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME)","volume":"18","author":"Lim","year":"2020","journal-title":"J. Transl. Med."},{"issue":"8","key":"10.1016\/j.bbi.2025.106098_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255608","article-title":"Natural killer-cell immunoglobulin-like receptors trigger differences in immune response to SARS-CoV-2 infection","volume":"16","author":"Littera","year":"2021","journal-title":"PloS One."},{"issue":"6","key":"10.1016\/j.bbi.2025.106098_b0145","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/ana.21695","article-title":"Killer immunoglobulin\u2010like receptor ligand HLA\u2010Bw4 protects against multiple sclerosis","volume":"65","author":"Lorentzen","year":"2009","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.bbi.2025.106098_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008904","article-title":"High-throughput interpretation of killer-cell immunoglobulin-like receptor short-read sequencing data with PING","volume":"17","author":"Marin","year":"2021","journal-title":"PLoS Comput. Biol."},{"issue":"7","key":"10.1016\/j.bbi.2025.106098_b0155","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.4049\/jimmunol.173.7.4273","article-title":"Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection\/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis","volume":"173","author":"Nelson","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbi.2025.106098_b0160","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ajhg.2016.06.023","article-title":"Defining KIR and HLA class I genotypes at highest resolution via high-throughput sequencing","volume":"99","author":"Norman","year":"2016","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.bbi.2025.106098_b0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/tan.14662","article-title":"A new strategy for systematically classifying HLA alleles into serological specificities","volume":"100","author":"Osoegawa","year":"2022","journal-title":"HLA."},{"key":"10.1016\/j.bbi.2025.106098_b0170","article-title":"Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells","volume":"8(84):eade5343","author":"Palmer","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.bbi.2025.106098_b0175","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev-immunol-042617-053149","article-title":"Genetics of natural killer cells in human health, disease, and survival","volume":"36","author":"Parham","year":"2018","journal-title":"Ann. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.bbi.2025.106098_b0180","first-page":"535","article-title":"Excess of activating killer cell immunoglobulin\u2011like receptors and lack of HLA-Bw4 ligands: a two\u2011edged weapon in chronic fatigue syndrome","volume":"4","author":"Pasi","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbi.2025.106098_b0185","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbi.2025.106098_b0190","first-page":"1763","article-title":"Immunogenomics of killer cell immunoglobulin-like receptor (KIR) and HLA class I: coevolution and consequences for human health","volume":"10","author":"Pollock","year":"2022","journal-title":"JACI. In Practice."},{"key":"10.1016\/j.bbi.2025.106098_b0195","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.12258","article-title":"Abundant CpG-sequences in human genomes inhibit KIR3DL2-expressing NK cells","volume":"9","author":"Pugh","year":"2021","journal-title":"PeerJ."},{"issue":"1","key":"10.1016\/j.bbi.2025.106098_b0200","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bioinformatics\/19.1.149","article-title":"Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits","volume":"19","author":"Purcell","year":"2003","journal-title":"Bioinformatics."},{"issue":"D1","key":"10.1016\/j.bbi.2025.106098_b0205","doi-asserted-by":"crossref","first-page":"D1234","DOI":"10.1093\/nar\/gks1140","article-title":"IPD\u2014the immuno polymorphism database","volume":"41","author":"Robinson","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.bbi.2025.106098_b0210","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity."},{"issue":"10","key":"10.1016\/j.bbi.2025.106098_b0215","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2009-12-256586","article-title":"A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2","volume":"116","author":"Sivori","year":"2010","journal-title":"Blood."},{"issue":"8","key":"10.1016\/j.bbi.2025.106098_b0220","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/jcp.2004.022681","article-title":"Association of chronic fatigue syndrome with human leucocyte antigen class II alleles","volume":"58","author":"Smith","year":"2005","journal-title":"J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.bbi.2025.106098_b0225","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/imm.13289","article-title":"The combinatorial diversity of KIR and HLA class I allotypes in Peninsular Malaysia","volume":"162","author":"Tao","year":"2021","journal-title":"Immunology."},{"issue":"10","key":"10.1016\/j.bbi.2025.106098_b0230","doi-asserted-by":"crossref","first-page":"6743","DOI":"10.4049\/jimmunol.180.10.6743","article-title":"Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?","volume":"180","author":"Thomas","year":"2008","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.bbi.2025.106098_b0235","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-3083.1994.tb03511.x","article-title":"Immunological abnormalities in patients with chronic fatigue syndrome","volume":"40","author":"Tirelli","year":"1994","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.bbi.2025.106098_b0240","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhepr.2019.09.003","article-title":"KIR\/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis","volume":"1","author":"Umemura","year":"2019","journal-title":"JHEP Rep."},{"issue":"6","key":"10.1016\/j.bbi.2025.106098_b0245","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.mehy.2015.10.011","article-title":"Myalgic encephalomyelitis, chronic fatigue syndrome: An infectious disease","volume":"85","author":"Underhill","year":"2015","journal-title":"Med. Hypotheses."},{"issue":"3","key":"10.1016\/j.bbi.2025.106098_b0250","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2370.2001.00235.x","article-title":"Lack of association between HLA genotype and chronic fatigue syndrome","volume":"28","author":"Underhill","year":"2001","journal-title":"Eur. J. Immunogenet."},{"issue":"1","key":"10.1016\/j.bbi.2025.106098_b0255","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12967-025-06281-0","article-title":"Time to correct the record on the global burden of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","volume":"23","author":"Vardaman","year":"2025","journal-title":"J. Transl. Med."},{"issue":"6013","key":"10.1016\/j.bbi.2025.106098_b0260","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or Adaptive Immunity? The Example of Natural Killer Cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science."},{"key":"10.1016\/j.bbi.2025.106098_b0265","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.3389\/fimmu.2018.02843","article-title":"Allele-level KIR genotyping of more than a million samples: workflow, algorithm, and observations","volume":"9","author":"Wagner","year":"2018","journal-title":"Front. Immunol."},{"issue":"7145","key":"10.1016\/j.bbi.2025.106098_b0270","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Wellcome Trust Case Control Consortium","year":"2007","journal-title":"Nat."},{"issue":"3","key":"10.1016\/j.bbi.2025.106098_b0275","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20051884","article-title":"Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function","volume":"203","author":"Yawata","year":"2006","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bbi.2025.106098_b0280","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S1471-4906(01)02113-5","article-title":"KIR expression shapes cytotoxic repertoires: a developmental program of survival","volume":"23","author":"Young","year":"2002","journal-title":"Trends. Immunol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125003332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159125003332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:05:57Z","timestamp":1778486757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159125003332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":56,"alternative-id":["S0889159125003332"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106098","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Killer cell immunoglobulin-like receptor (KIR) alleles suggested to be associated with myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2025.106098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106098"}}